Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022 - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Role of MRI, ultrasound, and computed tomography in the management of prostate cancer

N Mohsen - Pet Clin, 2022 - books.google.com
After a diagnosis of prostate cancer has been confirmed, anatomic imaging techniques
including ultrasound, computed tomography (CT), and multi-parametric MRI (mp-MRI) …

Novel imaging in detection of metastatic prostate cancer

CP Smith, A Laucis, S Harmon, E Mena… - Current oncology …, 2019 - Springer
Abstract Purpose of Review This review aims to highlight the limitations of current standard-
of-care prostate cancer (PCa) imaging and discuss novel clinical imaging in advanced …

Cost‐effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer

CL Barnett, MS Davenport, JS Montgomery… - BJU …, 2018 - Wiley Online Library
Objective To determine how best to use magnetic resonance imaging (MRI) and targeted
MRI/ultrasonography fusion biopsy for early detection of prostate cancer (PCa) in men with …

Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database

D Gabriele, D Collura, M Oderda, I Stura, C Fiorito… - World journal of …, 2016 - Springer
Purpose According to the current guidelines, computed tomography (CT) and bone
scintigraphy (BS) are optional in intermediate-risk and recommended in high-risk prostate …

From data to improved decisions: operations research in healthcare delivery

M Capan, A Khojandi, BT Denton… - Medical Decision …, 2017 - journals.sagepub.com
Background. The Operations Research Interest Group (ORIG) within the Society of Medical
Decision Making (SMDM) is a multidisciplinary interest group of professionals that …

A novel deep learning approach to extract Chinese clinical entities for lung cancer screening and staging

H Zhang, D Hu, H Duan, S Li, N Wu, X Lu - BMC Medical Informatics and …, 2021 - Springer
Background Computed tomography (CT) reports record a large volume of valuable
information about patients' conditions and the interpretations of radiology images from …

Impact of piflufolastat F‐18 PSMA PET imaging on clinical decision‐making in prostate cancer across disease states: A retrospective review

AT Arafa, A Jain, P Skrobanek, B Humphrey… - The …, 2023 - Wiley Online Library
Abstract Introduction Piflufolastat F‐18 (18F‐DCFPyL) prostate‐specific membrane antigen
(PSMA) positron emission tomography (PET) imaging is approved by the US food and drug …

A statewide intervention improves appropriate imaging in localized prostate cancer

P Hurley, A Dhir, Y Gao, B Drabik, K Lim, J Curry… - The Journal of …, 2017 - Elsevier
Purpose We implemented a statewide intervention to improve imaging utilization for the
staging of patients with newly diagnosed prostate cancer. Materials and Methods MUSIC …

Validation of the social security administration life tables (2004–2014) in localized prostate cancer patients within the Surveillance, Epidemiology, and End Results …

F Preisser, M Bandini, E Mazzone, S Nazzani… - European Urology …, 2019 - Elsevier
Backround Accurate life expectancy estimation is crucial in clinical decision-making
including management and treatment of clinically localized prostate cancer (PCa). Objective …